Recombinant shingles vaccine linked to lower dementia risk, especially in women

Study published in Nature Medicine found that the recombinant shingles vaccine is linked to a reduced risk of dementia. This protective effect was particularly notable in females, suggesting a potential advantage of the recombinant vaccine over the live vaccine.

Healthcare industry of the future: What to expect in the next 50 years

Developments in technology are moving forward rapidly and over the next 50 years, healthcare across the globe will change, including an increased use of AI

July 4, 2023

Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show

A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous

October 25, 2023

PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney | Psychedelic Invest

PharmAla Biotech Holdings Inc. (CSE: MDMA / OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA),

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.